Misonix to Participate in Upcoming March Investor Conferences
FARMINGDALE, N.Y., March 01, 2021 (GLOBE NEWSWIRE) Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announced that it will be participating in the upcoming Cowen 41
st Annual Healthcare Conference and the Oppenheimer 31
st Annual Healthcare Conference on March 4
th and March 16
th, respectively. Misonix Chief Executive Officer, Stavros Vizirgianakis, along with Joe Dwyer, Chief Financial Officer, will be available to host one-on-one meetings with investors who are registered to attend the conferences.
Cowen 41
Presentation: 9:50 a.m. ET
Oppenheimer 31
Presentation: 4:30 p.m. ET
Operator
Good morning, and welcome to Casper Sleep s fourth-quarter 2020 conference call. today s call is being recorded. I would like to turn the conference over to Norberto Aja, investor relations for Casper. Mr.
Aja, you may begin.
Investor Relations
Thank you, operator, and good morning, everyone. Thank you for joining the Casper Sleep 2020 fourth-quarter and full-year conference call. We ll get started in just a minute with management s comments and your questions. But before doing so, let me take a minute to read the safe harbor language.
This call will contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements made on this call that do not relate to matters of historical fact should be considered forward-looking statements, including statements regarding management s plans, strategies, goals, and objectives, our anticipated financial performance and the expected impact of novel coronavirus on our business.
Misonix to Report Fiscal 2021 Second Quarter Financial Results and Host Conference Call and Webcast on February 4
January 21, 2021 10:30 ET | Source: MISONIX, Inc. MISONIX, Inc. Farmingdale, New York, UNITED STATES
FARMINGDALE, N.Y., Jan. 21, 2021 (GLOBE NEWSWIRE) Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, announced today that it will report its fiscal 2021 second quarter financial results after the market closes on Thursday, February 4, 2021. The Company will host a conference call and webcast at 4:30 p.m. ET that day to review the results. Both the call and webcast are open to the general public.